Nyxoah S A (NYXH)

$2.86 -0.01 (-0.35%)
Market Cap 111.24M
Revenue (ttm) 11.34M
Net Income (ttm) -101.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -898.77%
Debt to Equity Ratio 0.83
Volume 38,200
Avg Vol 55,000
Day's Range N/A - N/A
Shares Out 38.76M
Stochastic %K 11%
Beta 1.66
Analysts Strong Sell
Price Target $10.75

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 32 1 022 23 55
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 9:34 PM
$NYXH RSI: 49.19, MACD: -0.1878 Vol: 0.22, MA20: 3.17, MA50: 3.91 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
bartwood
bartwood Apr. 2 at 2:45 PM
$NYXH
0 · Reply
erevnon
erevnon Mar. 23 at 2:19 PM
Cantor Fitzgerald reiterates Nyxoah $NYXH at Overweight and maintains the price target at https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 6:01 PM
$NYXH newer ticker behavior, still in discovery mode. Can get volatile as traders figure out range.
0 · Reply
AdrianVale
AdrianVale Mar. 20 at 4:35 PM
Watching: $DRMA $EDSA $NYXH $JAGU $WNW
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 19 at 9:18 PM
$NYXH Q4 '25 Earnings Results & Recap Nyxoah anticipates U.S. net revenue to grow approximately 25% sequentially in both Q1 2026 over Q4 2025, and Q2 2026 over Q1 2026, with international revenue following a typical seasonal pattern.
0 · Reply
bartwood
bartwood Mar. 16 at 1:53 PM
$NYXH
0 · Reply
mahesh_99
mahesh_99 Mar. 15 at 7:05 PM
$NYXH
0 · Reply
Lilingpeace
Lilingpeace Mar. 10 at 5:58 PM
$NYXH started initial positions here, hopefully Genio will take off
0 · Reply
Lilwopjob
Lilwopjob Mar. 3 at 8:47 PM
Is $NYXH going to eat $INSPS lunch? Position in neither but I’ve been researching / watching a couples months.
0 · Reply
Latest News on NYXH
Publication relating to transparency notifications

Fri, 20 Mar 2026 17:30:00 -0400 - 22 days ago

Publication relating to transparency notifications

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Thu, 19 Mar 2026 16:10:00 -0400 - 23 days ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Publication relating to transparency notification

Fri, 13 Mar 2026 17:30:00 -0400 - 4 weeks ago

Publication relating to transparency notification

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Wed, 11 Mar 2026 17:05:00 -0400 - 4 weeks ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Thu, 05 Mar 2026 16:05:00 -0500 - 5 weeks ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Information on the total number of voting rights and shares

Wed, 25 Feb 2026 16:30:00 -0500 - 6 weeks ago

Information on the total number of voting rights and shares

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Feb 18, 2026, 4:05 PM EST - 7 weeks ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 21, 2026, 4:05 PM EST - 2 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Publication relating to transparency notification

Jan 12, 2026, 1:00 AM EST - 3 months ago

Publication relating to transparency notification

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Dec 19, 2025, 4:05 PM EST - 4 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 17, 2025, 1:05 AM EST - 4 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Publication relating to transparency notifications

Dec 2, 2025, 4:30 PM EST - 4 months ago

Publication relating to transparency notifications

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 4 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 26, 2025, 1:45 AM EST - 4 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Information on the total number of voting rights and shares

Nov 20, 2025, 4:30 PM EST - 5 months ago

Information on the total number of voting rights and shares

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:36 PM EST - 5 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 13, 2025, 4:12 PM EST - 5 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 5 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 30, 2025, 5:10 PM EDT - 5 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Oct 6, 2025, 1:00 AM EDT - 6 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 23, 2025, 4:10 PM EDT - 7 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 15, 2025, 4:10 PM EDT - 7 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Nyxoah Announces Upcoming Investor Events

Sep 2, 2025, 4:30 PM EDT - 7 months ago

Nyxoah Announces Upcoming Investor Events

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 18, 2025, 4:10 PM EDT - 8 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 11, 2025, 1:00 AM EDT - 8 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Aug 8, 2025, 4:10 PM EDT - 8 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 9 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 9 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 10 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 11 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Fri, 16 May 2025 09:00:00 -0400 - 11 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Reports First Quarter Financial and Operating Results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH

Tue, 13 May 2025 13:35:00 -0400 - 11 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Fri, 09 May 2025 09:57:00 -0400 - 1 year ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. - NYXH

Mon, 05 May 2025 14:08:00 -0400 - 1 year ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. - NYXH

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 22, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 21, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 18, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 17, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 1 year ago

Conditional Issuance of Shares

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

NYXH

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NYXH

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 11, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

NYXH

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NYXH

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

NYXH

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

NYXH

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

NYXH

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 3:00 PM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 1 year ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 5:40 PM EDT - 1 year ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 9:34 PM
$NYXH RSI: 49.19, MACD: -0.1878 Vol: 0.22, MA20: 3.17, MA50: 3.91 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
bartwood
bartwood Apr. 2 at 2:45 PM
$NYXH
0 · Reply
erevnon
erevnon Mar. 23 at 2:19 PM
Cantor Fitzgerald reiterates Nyxoah $NYXH at Overweight and maintains the price target at https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 6:01 PM
$NYXH newer ticker behavior, still in discovery mode. Can get volatile as traders figure out range.
0 · Reply
AdrianVale
AdrianVale Mar. 20 at 4:35 PM
Watching: $DRMA $EDSA $NYXH $JAGU $WNW
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 19 at 9:18 PM
$NYXH Q4 '25 Earnings Results & Recap Nyxoah anticipates U.S. net revenue to grow approximately 25% sequentially in both Q1 2026 over Q4 2025, and Q2 2026 over Q1 2026, with international revenue following a typical seasonal pattern.
0 · Reply
bartwood
bartwood Mar. 16 at 1:53 PM
$NYXH
0 · Reply
mahesh_99
mahesh_99 Mar. 15 at 7:05 PM
$NYXH
0 · Reply
Lilingpeace
Lilingpeace Mar. 10 at 5:58 PM
$NYXH started initial positions here, hopefully Genio will take off
0 · Reply
Lilwopjob
Lilwopjob Mar. 3 at 8:47 PM
Is $NYXH going to eat $INSPS lunch? Position in neither but I’ve been researching / watching a couples months.
0 · Reply
notreload_ai
notreload_ai Feb. 26 at 7:46 PM
$INSP , $NYXH ... CMS resolves hypoglossal nerve stimulation reimbursement confusion by adding 6 new HCPCS codes (effective Jan 1, 2026), viewed as positive for Inspire & Nyxoah. https://notreload.xyz/cms-adds-hcpcs-codes-for-hgns-boost-for-inspire-nyxoah/
0 · Reply
InItToWinIt100
InItToWinIt100 Feb. 26 at 7:25 PM
$NYXH Out of nowhere! https://www.trade-ideas.com/share.php?code=Gr0mz3StGd380SJnyduBog5jhQsmkku0
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 6:00 PM
$NYXH RSI: 43.90, MACD: -0.0625 Vol: 0.14, MA20: 4.67, MA50: 4.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Amb8675309
Amb8675309 Feb. 7 at 12:34 AM
$NYXH forgot I was holding this- what’s going on that it’s up? Too busy nursing my ITRM position
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 4 at 2:41 AM
$NYXH RSI: 26.36, MACD: -0.0347 Vol: 0.18, MA20: 4.90, MA50: 4.80 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 22 at 10:34 PM
$NYXH
0 · Reply
Noobnr1
Noobnr1 Jan. 13 at 5:39 AM
$NYXH 🚀 netto gain increases with 348% 👏 $PHAR $BEAM $OMER $GILD 💎
0 · Reply
TheVirus0011
TheVirus0011 Dec. 29 at 11:09 PM
$NYXH OMG ??????
0 · Reply
HoneyHedge
HoneyHedge Dec. 25 at 9:25 AM
$NYXH The valuation debate now centers on reliability of delivery, with macro volatility magnifying operational missteps. Momentum turns durable only after multiple confirmations.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 19 at 6:10 PM
$NYXH
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 17 at 2:00 PM
$NYXH (+6.0% pre) New battery-free sleep apnea implant debuts in Dutch hospitals https://ooc.bz/l/87759
0 · Reply